EXPONENT INC

Listed Company

EXPOCIK 0000851520NasdaqLarge AcceleratedServices-Management Consulting ServicesDelawareFY ends Jan 1

Period

FY 2025

Revenue

$582.01M

Net Income

$106.01M

Total Assets

$777.52M

Equity

$390.34M

Shares Out

49.25M

Op. Cash Flow

$131.73M

Business

Exponent, Inc. is a science and engineering consulting firm that provides solutions to complex technical, safety, health, and environmental problems. It offers interdisciplinary consulting services including failure and accident analysis, experimental testing, computational modeling, regulatory and litigation support, design verification, and risk assessment. The company operates two reportable segments—Engineering and Other Scientific and Environmental and Health—organized into 16 technical practices such as biomechanics, materials and corrosion, thermal sciences, and health sciences. Exponent serves clients globally across industries (consumer products, energy, transportation, chemical, government, life sciences, insurance, and manufacturing) through project-based engagements, on-site investigations, laboratories, and advisory services.

Summary from filing dated 2025-02-28

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenues before reimbursements	537	518	497	464	435
Reimbursements	45	40	40	49	31
Revenues	582	559	537	513	466
Compensation and related expenses	342	330	320	264	278
Other operating expenses	49	46	42	35	33
Reimbursable expenses	45	40	40	49	31
General and administrative expenses	26	23	24	24	15
Total operating expenses	462	439	425	372	357
Operating income	120	120	111	141	109
Interest income	9	10	7	2	66,000
Miscellaneous income, net	18	18	17	−11	17
Income before income taxes	147	147	136	132	126
Provision for income taxes	41	38	36	30	25
Net income	106	109	100	102	101
Basic (in dollars per share)	2.08	2.13	1.96	1.98	1.92
Diluted (in dollars per share)	2.07	2.11	1.94	1.96	1.9
Basic (in shares)	51	51	51	52	53
Diluted (in shares)	51	52	52	52	53
Cash dividends declared per common share (in dollars per share)	1.2	1.12	1.04	0.96	0.8

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	222	259	187	161	298
Accounts receivable, net of allowance for contract losses and doubtful accounts of $ 7,478 and $6,141, respectively	182	161	167	170	140
Prepaid expenses and other current assets	24	27	25	18	15
Total current assets	428	447	380	349	453
Property, equipment and leasehold improvements, net	72	73	75	66	60
Operating lease right-of-use assets	73	75	25	18	14
Goodwill	9	9	9	9	9
Deferred income taxes	67	57	54	54	47
Deferred compensation plan assets	123	110	101	89	100
Other assets	5	6	4	2	2
Total assets	778	777	647	587	684
Accounts payable and accrued liabilities	31	22	22	29	25
Accrued payroll and employee benefits	121	119	112	106	104
Deferred revenues	19	16	22	19	20
Operating lease liabilities	7	5	6	5	5
Total current liabilities	178	163	162	159	153
Other liabilities	5	4	3	2	3
Deferred compensation plan liabilities	129	113	103	91	101
Operating lease liabilities	76	76	22	13	10
Total liabilities	387	356	291	266	267
Commitments and contingencies (Note 13)	—	—	—	—	—
Preferred stock, $0.001 par value; 2,000 shares authorized; no shares outstanding	—	—	—	—	—
Common stock, $0.001 par value; 120,000 shares authorized; 65,707 shares issued	66,000	66,000	66,000	66,000	66,000
Additional paid-in capital	370	346	321	301	281
Foreign currency translation adjustments	−2	−4	−3	−4	−2
Retained earnings	668	624	574	529	478
Treasury stock, at cost: 16,087 and 14,893 shares held, respectively	−646	−545	−537	−506	−341
Total stockholders equity	390	421	356	321	417
Total liabilities and stockholders equity	778	777	647	587	684

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net income	106	109	100	102	101
Depreciation and amortization of property, equipment and leasehold improvements	10	10	9	7	6
Provision for contract losses and doubtful accounts	3	4	3	3	2
Stock-based compensation	24	23	20	20	19
Deferred income tax provision	−10	−3	85,000	−7	−6
Accounts receivable	−23	2	−471,000	−33	−30
Prepaid expenses and other current assets	8	2	−7	−6	−4
Change in operating leases	3	3	−152,000	−7,000	−406,000
Accounts payable and accrued liabilities	8	436,000	−5	2	8
Accrued payroll and employee benefits	807,000	495,000	4	6	20
Deferred revenues	2	−5	3	−928,000	8
Net cash provided by operating activities	132	145	127	94	125
Capital expenditures	−9	−7	−16	−12	−7
Net cash used in investing activities	−9	−7	−16	−12	38
Payroll taxes for restricted stock units	−4	−7	−10	−13	−16
Repurchase of common stock	−97	−6	−24	−156	−7
Exercise of stock-based payment awards	2	6	2	2	3
Dividends and dividend equivalent rights	−62	−58	−54	−49	−43
Net cash used in financing activities	−160	−65	−86	−216	−63
Effect of foreign currency exchange rates on cash and cash equivalents	1	−739,000	705,000	−2	169,000
Net change in cash and cash equivalents	−37	72	26	−136	100

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro